Meeting Overview
8.5 AMA Category 1, AAFP, 8.5 AANP
Diabetes In Depth
Diabetes In Depth is a continuing medical education program designed to meet the education and practice needs of clinicians who regularly diagnose and manage patients with diabetes. At every session, leading experts will provide world-class information on the cormorbidities and risk factors associated with what has become one of the greatest health problems. Earn up to 8.5 AMA PRA Category 1 Credit(s)TM or 8.5 AANP contact hours of continuing education, at no cost.
Presented in collaboration with:
Program Objectives
Attend this continuing medical education activity and you will be able to:
- Incorporate essential clinical management tools, including self-monitoring of blood glucose, medical nutritional therapy, and patient education.
- Assess treatment strategies and implement patient-specific directed therapies.
- Analyze the methods and role of intensive glycemic control through early intervention and treatment advancement.
- Address multifactorial cardiovascular risk in the patient with diabetes, and strategies to manage cardiometabolic risk factors.
- Explore emerging and new perspectives in the treatment of diabetes.
Curriculum Developed by Course Directors:
Ken Fujioka, MD, Division of Endocrinology & Diabetes, Director of the Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, CA
M. Sue Kirkman, MD, Vice President, Clinical Affairs, American Diabetes Association, Alexandria, VA
|
Complimentary Education Materials courtesy of the American Diabetes Association
Attend this program and you will receive important provider and patient materials from the American Diabetes Association that can help your patients understand the cardiometabolic risks associated with diabetes, and help them to better achieve their health goals.
This activity is intended for primary care providers currently engaged in patient care.
Special Needs
In accordance with the Americans with Disabilities Act, Pri-Med Institute seeks to make this conference accessible to all. If you have a need which might require special accommodations, please call 877-4PRI-MED or email support@pri-med.com three weeks prior to the meeting.
Marketing Partners
Pri-Med partners with local healthcare associations, managed care organizations, and publications in order to ensure that all practicing clinicians have the opportunity to attend. Pri-Med would like to thank the following partners for this program to date:
Aetna, American Academy of Nurse Practitioners, CIGNA HealthCare, and Pennsylvania Medical Society.
Educational Grants
To date, the following organizations have provided educational grants in support of this Pri-Med activity:
Abbott ,
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company,
Merck & Co., Inc.,
and Novo Nordisk Inc..
Session Topics
This live program consists of 5 case-based sessions and 3 workshops. Select sessions below offer related, accredited Online CME activities. Participate in the online CME activities before the live session to prepare in advance or after the lecture to learn more about the topic. At the live program each lecture will be followed by a 15-minute networking break and complimentary lunch will be provided.
| Thursday, September 25, 2008 |
| 8:00 AM-9:15 AM | Prevention and Diagnosis of Type 2 Diabetes Learning Objectives:- Identify the cascade of factors--including insulin resistance and impaired beta-cell function--that contribute to the pathophysiology of type 2 diabetes
- Detail the role of timely lifestyle changes and pharmacotherapy in the prevention of type 2 diabetes
Lawrence S. Phillips, MD,
Professor of Medicine,
Division of Endocrinology,
Emory University School of Medicine,
Atlanta, GA |
| 9:15 AM-10:30 AM | The First Step: Managing Diabetes Through Noninsulin Therapy Description:1. Outline the initial treatment options for managing type 2 diabetes in a newly diagnosed patient.
2. Understand the parameters that guide when and how to step up pharmacotherapy in a patient who is not well controlled on monotherapy.
Howard A. Brand, MD,
Medical Director,
Sound Endocrinology,
Stonybrook, NY |
| 10:45 AM-11:30 AM | Workshop 1: Assessment of Special Populations and Risk Description:1. Recognize the degree to which ethnicity and age influence how patients approach the diagnosis and management of a chronic illness like diabetes.
2. Apply culturally sensitive principles to diabetes care in Latino, African American, and Asian populations.
Howard A. Brand, MD,
Medical Director,
Sound Endocrinology,
Stonybrook, NY |
| 11:45 AM-1:00 PM | Working Lunch: Insulin Therapy--Best Practices for Use Learning Objectives:- Discuss when and how to initiate insulin therapy in an insulin-naive patient.
Lawrence Blonde, MD, FACP, FACE,
Director, Ochsner Diabetes Clinical Research Unit,
Department of Endocrinology, Diabetes, and Metabolic Diseases,
Ochsner Clinic Foundation,
New Orleans, LA |
| 1:15 PM-2:00 PM | Workshop 2: Insulin Initiation and Intensification Description:1. Develop skill in calculating and titrating insulin doses using basal and premixed insulin.
2. Sketch out a scenario that calls for appropriate insulin titration in a patient with type 2 diabetes.Lawrence Blonde, MD, FACP, FACE,
Director, Ochsner Diabetes Clinical Research Unit,
Department of Endocrinology, Diabetes, and Metabolic Diseases,
Ochsner Clinic Foundation,
New Orleans, LA |
| 2:00 PM-3:15 PM | Dyslipidemia and Hypertension in the Diabetic Patient Learning Objectives:- Understand the parameters that define the amplified risk posed by these common comorbidities in patients with type 2 diabetes
- Apply the most current lipid and HTN management guidelines, with an eye on the specific goals in a patient with diabetes
Kelly Anne Spratt, DO,
Clinical Associate Professor of Medicine,
Director of the Women's Center for Cardiovascular Health,
University of Pennsylvania,
Philadelphia, PA |
| 3:30 PM-4:15 PM | Workshop 3: Assessment and Management of the Diabetic Foot Description:1. Understand how the complications and comorbidities of type 2 diabetes increase the risk of foot ulcers.
2. Learn how to do a comprehensive foot exam and identify "red flags" that warrant referral in high-risk patients.
John Giurini, DPM,
Chief,
Division of Podiatry,
Beth Isreal Deaconess Medical Center,
Boston, MA, Member of Harvard Medical Faculty Physicians (HMFP) at Beth Israel Deaconess Med,
Harvard Medical School,
Boston, MA |
| 4:15 PM-5:30 PM | New Perspectives in the Management of Obesity Description:1. Understand how obesity complicates the management of type 2 diabetes and compounds the risk of cardiovascular disease.
2. Detail the initial and "next step" treatment options in managing obesity in your type 2 diabetes patients.
Holly Wyatt, MD,
Center for Human Nutrition,
University of Colorado Health Sciences Center,
Aurora, CO |
